1. Home
  2. CRBP vs MRT Comparison

CRBP vs MRT Comparison

Compare CRBP & MRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$9.27

Market Cap

184.4M

Sector

Health Care

ML Signal

HOLD

Logo Marti Technologies Inc.

MRT

Marti Technologies Inc.

HOLD

Current Price

$1.43

Market Cap

159.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBP
MRT
Founded
2009
2018
Country
United States
Turkey
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Rental/Leasing Companies
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
184.4M
159.0M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
CRBP
MRT
Price
$9.27
$1.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$45.50
$3.58
AVG Volume (30 Days)
467.9K
55.6K
Earning Date
05-08-2026
08-08-2018
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,822,272.00
N/A
Revenue This Year
N/A
$72.36
Revenue Next Year
$116.00
$95.75
P/E Ratio
N/A
N/A
Revenue Growth
97.62
N/A
52 Week Low
$7.12
$1.12
52 Week High
$20.56
$3.11

Technical Indicators

Market Signals
Indicator
CRBP
MRT
Relative Strength Index (RSI) 57.06 33.34
Support Level $7.42 N/A
Resistance Level $9.57 $2.26
Average True Range (ATR) 0.50 0.13
MACD 0.21 -0.03
Stochastic Oscillator 87.14 41.16

Price Performance

Historical Comparison
CRBP
MRT

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About MRT Marti Technologies Inc.

Marti Technologies Inc is Turkiye's urban mobility platform, helping to solve the country's transportation needs through tech-enabled services powered by a single mobility super app. The Group aims to offer tech-enabled urban transportation services to consumers across Turkiye through three service offerings: ride-hailing, delivery, and two-wheeled electric vehicle services. The Group's ride-hailing service matches consumers with car, motorcycle, and taxi drivers. The Group's delivery service provides same-hour package delivery by leveraging the Group's existing network of car and motorcycle drivers and consumer base.

Share on Social Networks: